FDA and EMA Share Global Leadership in Drug Regulatory Processes
1 report, 1 independent
Updated Sep 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have shared the global regulatory leadership mantle. This discussion followed a U.K. MHRA Scientific Advice Meeting regarding a confirmatory Phase 3 trial. The leadership sharing is linked to Project Orbis, through which the FDA has approved products from the U.K. leadership.
From intelligencer.ca
Why it matters
The leadership sharing impacts the global standards for drug approval. This process is relevant to companies seeking market authorization for products in both the U.S. and the European Union.
Both the FDA and the EMA govern drug approval processes.
From intelligencer.ca
Who's involved
- FDAU.S. regulatory agency involved in global drug approval standards
- European Medicines AgencyHighest regulatory authority on medicines in the European Union
- companyLegal entity involved in the leadership sharing via Project Orbis
How this reaches others
Each traced step by step, with the reporting behind itKeep exploring
The entities involved
- FDA
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
Related events
- The FDA stated its intent to modernize regulatory processes to maintain leadership.
- OS Therapies, Inc. is seeking interim and final review data submissions from regulatory bodies while attending major global investment conferences.
- Administration actions, including FDA appointments, are promoting Bitcoin and digital assets.
- A drug tragedy led to regulatory changes, involving a Cincinnati-based company, and was praised by John F. Kennedy.
- Michael Davis takes a permanent leadership role at the FDA's Center for Drug Evaluation and Research following senior selections announced by the Department of Health & Human Services.